Synthesis and biological activity of mono- and disubstituted 1,2,4-triazole derivatives

Article abstract of DOI:10.3987/COM-09-11887

Novel mono- and disubstituted triazole derivatives were synthesized by condensation reactions of 1-aryl-3-hydrazinocarbonyl-5-oxopyrrolidinones with organic and inorganic cyanates, their structures were investigated and antimicrobial activity was evaluate

Full text of DOI:10.3987/COM-09-11887

HETEROCYCLES, Vol. 81, No. 3, 2010
649
HETEROCYCLES, Vol. 81, No. 3, 2010, pp. 649 - 658. © The Japan Institute of Heterocyclic Chemistry
Received, 14th December, 2009, Accepted, 26th January, 2010, Published online, 28th January, 2010
DOI: 10.3987/COM-09-11887
SYNTHESIS AND BIOLOGICAL ACTIVITY OF MONO- AND
DISUBSTITUTED 1,2,4-TRIAZOLE DERIVATIVES
Vytautas Mickevičius,a* Vida Intaitė,a Aušra Voskienė,a Kristina
Kantminienė,b Maryna Stasevych,c Olena Komarovska-Porokhnyavets,c and
Volodymyr Novikovc
aDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų
19, LT-50254 Kaunas, Lithuania, (E-mail: Vytautas.Mickevicius@ktu.lt),
bDepartment of General Chemistry, Kaunas University of Technology, Radvilėnų
19, LT-50254 Kaunas, Lithuania, and cDepartment of Technology of Biologically
Active Substances, Pharmacy and Biotechnology, Institute of Chemistry and
Chemical Technology, National University “Lviv Politechnic”, Bandera str. 12,
79013, Lviv-13, Ukraine
Abstract – Novel mono- and disubstituted triazole derivatives were synthesized
by condensation reactions of 1-aryl-3-hydrazinocarbonyl-5-oxopyrrolidinones
with organic and inorganic cyanates, their structures were investigated and
antimicrobial activity was evaluated.
INTRODUCTION
Nitrogen-containing five-membered heterocyclic compounds, azoles, diazoles, triazoles, and their
derivatives, are especially important and widespread natural products which can also be successfully
synthesized in the laboratory. Synthetic compounds of this class participate in biochemical processes and
often have a wide range of biological activity. 1,2,4-Triazoles are associated with diverse
pharmacological activities such as anti-inflammatory,1,2 antiviral,3,4 anticancer,5,6 antitubercular,7,8
antifungal and antimicrobial.9–15
Cyclocondensation of carboxylic acid hydrazides is a widely known method for the synthesis of azoles.
The goal of this work was investigation of the reactions of 1-aryl-3-hydrazinocarbonyl-5-oxopyrrolidines
1a–c with organic and inorganic cyanates and thiocyanates aiming to synthesize variously substituted
triazole systems, and to determine the structures of the synthesized compounds by spectroscopic methods.

650
HETEROCYCLES, Vol. 81, No. 3, 2010
The results of the assessment of the antimicrobial activity of the newly synthesized compounds are
reported.
RESULTS AND DISCUSSION
In
this
work,
2-[(5-oxo-1-phenylpyrrolidin-3-yl)carbonyl]hydrazinecarboxamide
(2b),
(2a),
2-{[1-(4-chlorophenyl)-5-oxopyrrolidin-3-yl]carbonyl}hydrazinecarboxamide
and
2-{[1-(4-bromophenyl)-5-oxopyrrolidin-3-yl]carbonyl}hydrazinecarboxamide (2c) were prepared by
heating under reflux 1-aryl-3-hydrazinocarbonyl-5-oxopyrrolidines 1a–c with sodium cyanate in dilute
1
13
acetic acid (Scheme). The structures of the synthesized compounds were confirmed by the IR, H, C
1
NMR, mass spectra and elemental analysis data. H NMR spectra of 2a–c have disclosed that these
compounds exist as rotamers in DMSO-d6 solution. For example, in the spectrum for 2a the NH protons
in NHCONH2 fragment are observed as two sets of resonances due to the restricted rotation around the
CO-NH bond indicating the existence of E/Z izomers with the ratio 0.90:0.10. Since the spectral line
corresponding to the Z isomer is more shielded and, thus, is always observed at higher magnetic field, the
conclusion can be drawn that the Z isomers predominate in this case. The protons of NHCOCHpyrrolid give
a double set of spectral lines as well, but in the opposite order of intensities with the ratio of 0.15:0.85.
Therefore, rotation of these two fragments around the amide bond is stabilized differently by hydrogen
bonding (between molecules of the compound and solvent).
O
O
N
R
N
PhOCN
H
O
R
N
H
NH2
N
N
N
O
H
H
O
1 a-c
NaOCN,
AcOH
KSCN,
AcOH
4 a-c
O
2 % NaOH
O
O
O
R
N
H
N
N
R
NH
N
N
NH
R
N
N
H
NH2
S
N
O
O
N
H
2 a-c
3 a-c
5 a-c
R = a - H, b - Cl, c - Br
Scheme
The analogous reaction of 1a–c with potassium thiocyanate instead of sodium cyanate resulted in the
formation of different structure compounds which precipitated from the reaction mixture already while

HETEROCYCLES, Vol. 81, No. 3, 2010
651
1
heated. The analysis of the H and 13C NMR spectra of these compounds revealed that the cyclic
compounds, 1-aryl-4-(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)pyrrolidin-2-ones 3a–c, were obtained.
1
Their H NMR spectra indicate the NH/SH tautomerism. For example, in the spectrum for 3b the
intensity ratio of spectral lines attributed to NH proton (13.37 ppm) and SH proton (1.94 ppm) is
0.57:0.43.
The reactions of 1a–c with phenyl isocyanate were carried out in methanol under reflux. The structures of
the obtained 2-(1-aryl-3-carbonyl-5-oxopyrrolidinyl)-N-phenylhydrazinocarboxamides 4a–c were
identified by the analysis of their 1H and 13C NMR spectra. The 1H NMR spectrum for 4a shows that the
influence of benzene ring on the shielding of NH group proton is weaker than the one of -NHCO-
fragment, therefore, the NH proton in CONHPh fragment is more shielded than the other NH proton at
the same carbonyl group (NHCONH). In the 13C NMR spectrum for this compound, the characteristic
signals assigned to pyrrolidinone carbons and four resonances (C-2, C-3 and C-2”, C-3”, double intensity)
for each benzene ring are observed. Three carbonyl carbon atoms resonate at 155 ppm (-NHCONH),
171.88 ppm (pyrrolidinone ring), and 172.51 ppm (CONH). The NMR spectra for 4a–c, have revealed
that in the DMSO-d6 solutions these compounds, the same as 2a–c, exist as a mixture of rotamers due to
the restricted rotation around the amide bonds.
As known from the literature, semicarbazides can undergo cyclization to diazole and triazole derivatives.
In this work, cyclization of phenylhydrazinocarboxamides 4a–c in 2% NaOH solution provided the
corresponding 1,2,4-triazol-3-ones 5a–c. The formation of cyclic compounds was confirmed by their
NMR spectra which display resonances characteristic to this five-membered heterocycle. For example, in
the 1H NMR spectrum for 5b the signal of NH group proton is observed at 13.86 ppm, whereas, in the 13C
NMR spectrum C=N group carbon resonates at 152.71 ppm, and the C=O group carbon gives a signal at
168.31 ppm.
ANTIMICROBIAL ACTIVITY
Antimicrobial activity of the synthesized compounds 2a-c, 3a-c, 4a-c, and 5c against Escherichia coli,
Staphylococcus aureus, Mycobacterium luteum, Candida tenuis and Aspergillus niger strains was
evaluated by diffusion method in agar (data of inhibition zone of microorganisms) and by “serial dilution”
method (determination of minimal bacteriostatic (MBSC) and minimal bactericidic (MBCC)
concentrations, minimal fungistatic (MFSC) and minimal fungicidic (MFCC) concentrations).16,17
Data obtained by the first method revealed that 2a, 3a, and 3c showed antibacterial and antifungal activity
at the indicated concentrations (Table 1).

652
HETEROCYCLES, Vol. 81, No. 3, 2010
Table 1. Antibacterial and fungicidal activities of the synthesized compounds determined by diffusion
method in agar
Inhibition diameter of microorganism growth, mm
Antibacterial activity
Fungicidal activity
C. tenuis Asp. niger
E.coli
St.aureus
Myc.luteum
0.5
0.5
1.0
0.5
8.0
0
0
0
0
0
0
0
0
2a
3a
11.0
7.0
7.0
12.3
9.0
0
0
0
0
0
0
3c
As seen from the data in Table 2, substances with antibacterial and fungicidal activity in low
concentrations are identified among the synthesized compounds by “serial dilution” method. Compounds
3a and 3c had good antibacterial activity against St. aureus; 3а–c, and 5с were active against Myc. luteum.
Activity of the other compounds in the investigated concentrations was not detected.
Table 2. Antibacterial and fungicidal activity of the synthesized compounds determined by “serial
dilution” method
Bacteria cultures
Fungi cultures
C. tenuis Asp. niger
E.coli
St.aureus
Myc.luteum
MBCS, MBCC, MBCS, MBCC, MBCS, MBCC, MFSC, MFCC, MFSC, MFCC,
g cm-3 g cm-3 g cm-3 g cm-3 g cm-3 g cm-3 g cm-3 g cm-3 g cm-3 g cm-3
+
+
+
+
+
+
*
+
+
+
+
+
*
250.0
+
*
+
+
+
+
+
+
+
*
2a
2b
2c
3a
3b
3c
4a
4b
+
+
+
500.0
250.0
15.6
125.0
31.2
+
+
+
+
*
500.0
7.8
*
+
+
+
31.2
+
250.0
+
62.5
500.0
62.5
+
15.6
250.0
62.5
+
+
+
62.5
31.2
+
500.0
+
125.0
+
500.0
+
500.0
+
+
+
+
+
+
+
+
+
+
125.0
*
+

HETEROCYCLES, Vol. 81, No. 3, 2010
653
+
+
+
+
+
+
+
+
+
+
500.0
500.0
*
*
+
+
+
+
4c
5c
250.0
500.0
+ – growth of microorganisms;
* – in the investigated concentrations the indexes of biocidic effect were not determined.
Investigation of fungicidal activity of the synthesized compounds showed that biocidic effect against Asp.
niger practically was not determined in concentrations 500 g cm-3 and lower. Yeast culture of fungus C.
tenuis appeared sensitive to majority of the tested compounds. Among them, 3а–c had effective indexes
of fungistatic activity in concentrations 7.8–62.5 g cm-3 and showed fungicidal activity in concentrations
15.6–250 g cm-3.
CONCLUSIONS
The convenient synthesis route of 1,2,4-triazole derivatives containing aromatic and 2-pyrrolidinone
substituents from the corresponding carbohydrazides is reported. The carried out investigations have
revealed that 1-aryl-4-(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)pyrrolidin-2-ones 3а–c show good
antibacterial and fungicidal activities at low concentrations in relation to the cultures Staphylococcus
aureus, Mycobacterium luteum, and Candida tenuis.
EXPERIMENTAL
Melting points were determined on an Auto probe analyzer APA 1 and are uncorrected. NMR spectra
were recorded on a Varian Unity Inova (300 MHz) spectrometer using DMSO-d6 as a solvent. Chemical
1
shifts (δ) are reported in parts per million (ppm) relative to internal standard TMS (0 ppm) for H NMR,
and DMSO-d6 (39.5 ppm) for 13C NMR. The IR spectra were measured as potassium bromide pellets on a
Perkin–Elmer Spectrum BX FT–IR spectrometer. Elemental analyses (C, H, N) were performed on an
Elemental Analyzer CE-440. Silica gel plates (Silufol UV-254) were used for analytical purposes.
General procedure for the preparation of 2-(1-Aryl-3-carbonyl-5-oxopyrrolidinyl)-
hydrazinocarboxamides 2a-c. A mixture of 1a-c (0.01 mol), sodium cyanate (0.03 mol), water (20 mL)
and glacial acetic acid (5 mL) was heated under reflux for 1 h and cooled down. The crystalline
precipitate 2a–c was filtered, washed with water, and recrystallized from the appropriate solvent.
2-[(5-Oxo-1-phenylpyrrolidin-3-yl)carbonyl]hydrazinecarboxamide (2a). Yield 2.00 g (76%), mp
183–184 C (from water). 1H NMR (300 MHz, DMSO-d6):  2.60–2.80 (m, 2H, CH2CO), 3.20–3.30 (m,
1H, CH), 3.85–4.05 (m, 2H, NCH2), 6.02 (s, 2H (0.90), (Z) NH2), 6,25 (s, 2H (0.10), (E) NH2), 7.11–7.65

654
HETEROCYCLES, Vol. 81, No. 3, 2010
(m, 5H, Har), 7.83 (s, 1H (0.90), (Z) NHCONH2), 8.20 (s, 1H (0.10), (E) NHCONH2), 9.12 (s, 1H (0.15),
13
(Z) NHCOCHpyrrolid), 9.78 (s, 1H (0.85), (E) NHCOCHpyrrolid). C NMR (75 MHz, DMSO-d6):  33.72,
35.45, 50.38, 119.29, 123.96, 128.62, 139.08, 158.72, 172.17. IR (KBr):  3568, 3437, 3224 (2NH, NH2),
1736, 1690, 1648 (3C=O) cm-1. MS (APCI, 20V): m/z 263 (M+H)+ (30%), 264 (M+1+H)+ (10%). Anal.
Calcd for C12H14N4O3: C, 54.96; H, 5.38; N, 21.36. Found: C, 55.08; H, 5.25; N, 21.55.
2-{[1-(4-Chlorophenyl)-5-oxopyrrolidin-3-yl]carbonyl}hydrazinecarboxamide (2b). Yield 1.78 g
1
(60%), mp 193–194 C (from MeOH). H NMR (300 MHz, DMSO-d6):  2.61–2.82 (m, 2H, COCH2),
3.20–3.30 (m, 1H (0.87), CH), 3.44–3.53 (m, 1H (0.13), CH), 3.84–4.04 (m, 2H, NCH2), 6.02 (br.s, 2H
(0.89), (Z) NH2), 6.25 (br.s, 2H (0.11), (E) NH2), 7.40–7.71 (m, 4H, Har), 7.82 (br.s, 1H (0.87), (Z)
NHCONH2), 8.13 (br.s, 1H (0.13), (E) NHCONH2), 9.14 (br.s, 1H (0.13), (Z) CHCONH), 9.77 (br.s, 1H
13
(0.87), (E) CHCONH). C NMR (75 MHz, DMSO-d6):  33.54, 35.35, 50.15, 115.72, 121.01, 132.01,
135.24, 138.59, 159.61, 172.14. IR (KBr):  3481 (NH), 3320–3150 (NH+NH2), 1716, 1668, 1590 (C=O)
cm-1. MS (APCI, 20V): m/z 297 (M+H)+ (40%), 299 (M+2+H)+ (20%). Anal. Calcd for C12H13ClN4O3: C,
48.58; H, 4.42; N, 18.88. Found: C, 48.39; H, 4.60; N, 18.73.
2-{[1-(4-Bromophenyl)-5-oxopyrrolidin-3-yl]carbonyl}hydrazinecarboxamide (2c). Yield 2.10 g
1
(62%), mp 188–189 C (from water). H NMR (300 MHz, DMSO-d6):  2.60–2.81 (m, 2H, CH2CO),
3.22–3.31 (m, 1H, CH), 3.83–4.03 (m, 2H, NCH2), 6.00 (s, 2H (0,81), (Z) NH2), 6.23 (s, 2H (0.19), (E)
NH2), 7.53–7.64 (m, 4H, Har), 7.80 (s, 1H (0.89), (Z) NHCONH2), 8.08 (s, 1H (0.11), (E) NHCONH2),
9.13 (br.s, 1H (0.14), (Z) NHCOCHpyrrolid), 9.75 (br.s, 1H (0.86), (E) NHCOCHpyrrolid). 13C NMR (75
MHz, DMSO-d6):  33.56, 35.44, 50.25, 115.78, 121.08, 131.41, 134.44, 138.37, 158.71, 172.16. IR
(KBr):  3447, 3293, 3196, 3069 (NH, NH2), 1713, 1682, 1618 (3C=O) cm-1. MS (APCI, 20V): m/z 341
(M+H)+ (20%), 343 (M+2+H)+ (20%), 363 (M+Na)+ (100%), 365 (M+Na+1+H)+ (95%). Anal. Calcd for
C12H13BrN4O3: C, 42.25; H, 3.84; N, 16.42. Found: C, 42.45; H, 3.74; N, 16.25.
General procedure for the preparation of 1-Aryl-4-(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-
3-yl)pyrrolidin-2-ones 3a–c. A mixture of 1a–c (5 mmol), potassium thiocyanate (15 mmol) and glacial
acetic acid (5 mL) was heated under reflux for 20 h, diluted with water (10 mL), and cooled down.
Precipitate 3a–c was filtered, washed with water, and recrystallized from 50% acetic acid.
1-Phenyl-4-(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)pyrrolidin-2-one (3a). Yield 0.54 g (41%), mp
1
267–268 C. H NMR (300 MHz, DMSO-d6):  1.86 (s, 0.2H, SH), 2.60–2.85 (m, 2H, CH2CO),
3.27–3.35 (m, 1H, CH), 3.85–4.10 (m, 2H, NCH2), 7.11–7.65 (m, 5H, Harom), 10.2 (s, 0.8H, NH). 13C
NMR (75 MHz, DMSO-d6):  33.41 (C-4„), 35.21 (C-3„), 50.10 (C-5„), 119.02 (C-2), 123.72 (C-4),
128.34 (C-3), 138.73 (C-1), 154.31 (Ca), 165.55 (Cd), 171.38 (C-2„). IR (KBr):  3213, 3063 (2NH), 1680
(C=O), 1599 (C=N), 1235 (C=S) cm-1. MS (APCI, 20V): m/z 261(M+H)+ (20%), 262 (M+1+H)+ (30%).

HETEROCYCLES, Vol. 81, No. 3, 2010
655
Anal. Calcd for C12H12N4OS: C, 55.37; H, 4.65; N, 21.52. Found: C, 55.18; H, 4.70; N, 21.42.
1-(4-Chlorophenyl)-4-(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)pyrrolidin-2-one (3b). Yield 0.66 g
1
(45%), mp 246–247 C. H NMR (300 MHz, DMSO-d6):  1.94 (s, 0.43H, SH), 2.74–2.96 (m, 2H,
CH2CO), 3.70–3.81 (m, 1H, CH), 3.97–4.17 (m, 2H, NCH2), 7.43, 7.67 (2d, 4H, J = 9.1 Hz, Har), 13.37,
13
13.40 (2s, 0.57H + 1H, NH-C=S + NH). C NMR (75 MHz, DMSO–d6):  27.95 (C-4„), 36.13 (C-3„),
50.76 (C-5„), 121.03 (C-2), 127.95 (C-4), 128.59 (C-3), 137.89 (C-1), 152.51 (Ca), 166.74 (Cd), 171.58
(C-2„). IR (KBr):  3101, 2930 (2NH), 1664 (C=O), 1586 (C=N), 1319 (C=S) cm-1. MS (APCI, 20V):
m/z 295 (M+H)+ (100%), 297 (M+2+H)+ (40%). Anal. Calcd for C12H11ClN4OS: C, 48.90; H, 3.76; N,
19.01. Found: C, 48.72; H, 3.94; N, 19.20.
1-(4-Bromophenyl)-4-(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)pyrrolidin-2-one (3c). Yield 0.76 g
1
(45%), mp 229–230 C. H NMR (300 MHz, DMSO-d6):  1.88 (s, 0.2H, SH), 2.72–2.94 (m, 2H,
CH2CO), 3.71–3.76 (m, 1H, CH), 3.94–4.15 (m, 2H, NCH2), 7.50-7.61 (m, 4H, Har), 13.51 (s, 1H, NH).
13C NMR (75 MHz, DMSO-d6):  27.14, 35.36, 49.90, 115.26, 120.56, 130.69, 137.48, 151.70, 165.92,
170.81. IR (KBr):  2938, 2867 (2NH), 1660 (C=O), 1492 (C=N), 1320 (C=S) cm-1. MS (APCI, 20V):
m/z 339 (M+H)+ (25%), 341 (M+2+H)+ (20%), 362 (M+Na)+ (40%), 363 (M+Na+H)+ (70%). Anal. Calcd
for C12H11BrN4OS: C, 42.48; H, 3.24; N, 15.52. Found: C, 43.30; H, 3.32; N, 15.33.
General procedure for the preparation of 2-(1-Aryl-3-carbonyl-5-oxopyrrolidinyl)-N-
phenylhydrazinocarboxamides 4a–c. The mixture of 1a–c (0.01 mol), phenyl isocyanate (0.02 mol) and
MeOH (15 mL) was heated under reflux for 2 h and cooled down. The precipitated 4a–c was filtrated,
washed with MeOH, and recrystallized from 1,4-dioxane.
2-(1-Phenyl-3-carbonyl-5-oxopyrrolidinyl)-N-phenylhydrazinocarboxamide (4a). Yield 2.46 g (73%),
mp 210–211 C. 1H NMR (300 MHz, DMSO-d6):  2.63–2.86 (m, 2H, CH2CO), 3.26–3.37 (m, 1H, CH),
3.88–4.10 (m, 2H, NCH2), 6.97–7.67 (m, 10H, Har), 8.11, 8.44 (2s, 2H (0.89:0.11), CONHPh), 8.80, 9.02
(2s, 1H (0.89:0.11), NHCONH), 9.26, 9.95 (2s, 1H (0.15:0.85), NHCOCHpyrrolid). 13C NMR (75 MHz,
DMSO-d6):  33.76 (C-4’), 35.54 (C-3’), 50.43 (C-5’), 118.49 (C-2”), 119.38 (C-2), 121.94 (C-4”),
124.06 (C-4), 128.70 (C-3 and C-3”), 139.14, 139.53 (C-1 and C-1”), 155.23 (NHCONH), 171.88 (C-2’),
172.51 (CONH). IR (KBr):  3325, 3200, 3061 (3NH), 1679, 1611, 1594 (3C=O) cm-1. MS (APCI, 20V):
m/z 339 (M+H)+ (40%), 340 (M+1+H)+ (20%). Anal. Calcd for C18H18N4O3: C, 63.89; H, 5.36; N, 16.56.
Found: C, 63.79; H, 5.38; N, 16.45.
2-(1-(4-Chlorophenyl)-3-carbonyl-5-oxopyrrolidinyl)-N-phenylhydrazinocarboxamide (4b). Yield
1.90 g (51%), mp 225–226 C. 1H NMR (300 MHz, DMSO-d6):  2.63–2.87 (m, 2H, CH2CO), 3.27–3.37
(m, 1H, CH), 3.87–4.10 (m, 2H, NCH2), 6.92–7.73 (m, 9H, Har), 8.10, 8.42 (2s, 2H (0.88:0.12),
CONHPh), 8.79, 9.01 (2s, 1H (0.88:0.12), NHCONH), 9.26, 9.95 (2s, 1H (0.13:0.87), NHCOCHpyrrolid).

656
HETEROCYCLES, Vol. 81, No. 3, 2010
13C NMR (75 MHz, DMSO-d6):  33.65 (C-4’), 35.49 (C-3’), 50.34 (C-5’), 118.47 (C-2”), 120.82 (C-2),
121.92 (C-4”), 127.76 (C-4), 128.57, 128.63 (C-3 and C-3”), 138.01 (C-1), 139.51 (C-1”), 155.20
(NHCONH), 172.10, 172.41 (CONHNH or C-2’). IR (KBr):  3327, 3198, 3113 (3NH), 1680, 1614,
1594 (3C=O) cm-1. MS (APCI, 20V): m/z 373 (M+H)+ (70%), 375 (M+2+H)+ (30%). Anal. Calcd for
C18H17ClN4O3: C, 57.99; H, 4.60; N, 15.03. Found: C, 57.83; H, 4.60; N, 14.85.
2-(1-(4-Bromophenyl)-3-carbonyl-5-oxopyrrolidinyl)-N-phenylhydrazinocarboxamide (4c). Yield
3.17 g (76%), mp 218–219 C. 1H NMR (300 MHz, DMSO-d6):  2.73–2.97 (m, 2H, CH2CO), 3.39–3.42
(m, 1H, CH), 3.96–4.19 (m, 2H, NCH2), 7.03–7.76 (m, 9H, Har), 8.20 (s, 1H, CONHPh), 8.89 (s, 1H,
NHCONH), 10.06 (s, 1H, NHCOCHpyrrolid). 13C NMR (75 MHz, DMSO-d6):  33.58, 35.45, 50.22,
115.81, 118.40, 121.09, 121.86, 128.57, 131.42, 138.36, 139.44, 155.14, 172.073, 172.34. IR (KBr): 
3333, 3259, 3230 (3NH), 1702, 1616, 1597 (3C=O) cm-1. MS (APCI, 20V): m/z 417(M+H)+ (20%), 419
(M+2+H)+ (10%), 439 (M+Na)+ (95%), 441 (M+Na+1+H)+ (100%). Anal. Calcd for C18H17BrN4O3: C,
51.81; H, 4.11; N, 13.43. Found: C, 52.00; H, 4.22; N, 13.49.
General procedure for the preparation of 5-(1-Aryl-5-oxopyrrolidin-3-yl)-4-phenyl-2,4-dihydro-
1,2,4-triazol-3-ones 5a–c. The mixture of 4a–c (1 mmol) and 2% aqueous NaOH solution (10 mL) was
heated under reflux for 3 h, cooled down, and acidified with dilute HCl (1:1) to pH 2. The precipitated
5a–c was filtered, washed with water, dried, and recrystallized from 1,4-dioxane.
5-(1-Phenyl-5-oxopyrrolidin-3-yl)-4-phenyl-2,4-dihydro-1,2,4-triazol-3-one (5a). Yield 0.14 g (44%),
1
mp 88–89 C. H NMR (300 MHz, DMSO-d6):  2.54–2.78 (m, 2H, CH2CO), 3.57–3.66 (m, 1H, CH),
3.82–4.8 (m, 2H, NCH2), 7.10–7.66 (m, 10H, Har), 11.85 (s, 1H, NH). 13C NMR (75 MHz, DMSO-d6): 
27.47 (C-4’), 35.26 (C-3’), 49.87 (C-5’), 119.21 (C-2), 127.49 (C-4), 128.30 (C-3”), 128.60 (C-3), 129.23
(C-2”), 130.08 (C-4), 132.31 (C-1”), 138.59 (C-1), 154.26 (Ca), 167.47 (C=O), 171.96 (C-2’). IR (KBr): 
3105 (NH), 1699, 1685 (2C=O), 1598 (C=N) cm-1. MS (APCI, 20V): m/z 321 (M+H)+ (100%), 322
(M+1+H)+ (30%), 323 (M+2+H)+ (10%). Anal. Calcd for C18H16N4O2: C, 67.49; H, 5.03; N, 17.49.
Found: C, 67.31; H, 5.23; N, 17.60.
5-[1-(4-Chlorophenyl)-5-oxopyrrolidin-3-yl]-4-phenyl-2,4-dihydro-[1,2,4]triazol-3-one (5b). Yield
1
0.2 g (56%), mp 173–174 C. H NMR (300 MHz, DMSO-d6):  2.56–2.80 (m, 2H, CH2CO), 3.50–3.63
(m, 1H, CH), 3.82–4.09 (m, 2H, NCH2), 7.39–7.63 (m, 9H, Har), 13.86 (s, 1H, NH). 13C NMR (75 MHz,
DMSO-d6):  27.60 (C-4’), 35.90 (C-3’), 50.34 (C-5’), 120.99 (C-2), 127.86 (C-4), 128.46 (C-3”), 128.51
(C-3), 129.51 (C-2”), 129.66 (C-4), 133.40 (C-1”), 137.71 (C-1), 152.71 (Ca), 168.31 (C=O), 171.30
(C-2’). IR (KBr):  3197 (NH), 1698, 1688 (2C=O), 1495 (C=N) cm-1. MS (APCI, 20V): m/z 355
(M+H)+ (100%), 357 (M+2+H)+ (40%). Anal. Calcd for C18H15ClN4O2: C, 60.94; H, 4.26; N, 15.79.
Found: C, 60.87; H, 4.39; N, 15.84.

HETEROCYCLES, Vol. 81, No. 3, 2010
657
5-[1-(4-Bromophenyl)-5-oxopyrrolidin-3-yl]-4-phenyl-2,4-dihydro-[1,2,4]triazol-3-one (5c). Yield
0.28 g (70%), mp 186–187 C. 1H NMR (300 MHz, DMSO-d6):  2.55–2.75 (m, 2H, CH2CO), 3.59–3.62
13
(m, 1H, CH), 3.80–4.0 (m, 2H, NCH2), 7.46–7.58 (m, 9H, Har), 11.83 (s, 1H, NH). C NMR (75 MHz,
DMSO-d6):  27.62, 35.92, 51.34, 119.31, 127.76, 128.48, 128.62, 129.45, 130.02, 133.42, 137.86,
153.40, 168.51, 171.86. IR (KBr):  3045 (NH), 1709, 1695 (2C=O), 1495 (C=N) cm-1. MS (APCI, 20V):
m/z 399 (M+H)+ (40%), 401 (M+2+H)+ (40%), 421 (M+Na)+ (95%), 423 (M+Na+1+H)+ (95%). Anal.
Calcd for C18H15BrN4O2: C, 51.55; H, 3.79; N, 12.21. Found: C, 51.58; H, 3.81; N, 12.03.
Evaluation of antimicrobial activity. Antimicrobial activity of the compounds was evaluated by
diffusion in peptone on solid nutrient medium (nutrient agar for bacteria, wort agar for fungi). The
microbial loading was 109 cells cm-3. The duration of incubation for bacteria was 24 h at 35 °С and 48–72
h at 28–30 °С for fungi.
The determination of minimal bacteriostatic and minimal bactericidic concentrations (MBSC and MBCC),
minimal fungicidic and minimal fungistatic concentrations (MFCC and MFSC) of the synthesized
compounds by “serial dilution” was carried out. The certain volume of solution of the compound in
DMSO was brought in nutrient medium (nutrient meat-extract for bacteria, wort for fungi). The inoculum
of bacteria and fungi was inoculated in nutrient medium. The duration of incubation was 24–72 h at 37 °С
for bacteria and at 30 °С for fungi. The results were estimated by the presence or absence of growth of the
microorganisms.
ACKNOWLEDGEMENTS
Financial support by the Lithuania Science and Studies Foundation is gratefully acknowledged.
REFERENCES
1. K. Sung and A-R. Lee, J. Heterocycl. Chem., 1992, 29, 1101.
2. G. Mekuskiene, S. Tumkevicius, and P. Vainilavicius, J. Chem. Res. (S), 2002, 213.
3. J. S. Barradas, M. I. Errea, N. B. D‟Accorso, C. S. Sepúlveda, L. B. Talarico, and E. B. Damonte,
Carbohydr. Res., 2008, 343, 2468.
4. Y. Li, Sh. Sun, Q. Guo, L. Ma, Ch. Shi, L. Su, and H. Li, J. Antimicrob. Chemother., 2008, 61, 577.
5. B. S. Holla, K. N. Poojary, B. S. Rao, and M. K. Shivananda, Eur. J. Med. Chem., 2002, 37, 511.
6. B. S. Holla, B. Veerendra, M. K. Shivananda, and B. Poojary, Eur. J. Med. Chem., 2003, 38, 759.
7. K. Walczak, A. Gondela, and J. Suwiński, Eur. J. Med. Chem., 2004, 39, 849.
8. M. S. Karthikeyan, B. S. Holla, B. Kalluraya, and N. S. Kumari, Monatsh. Chem. Chem. Mon., 2007,
138, 1309.

658
HETEROCYCLES, Vol. 81, No. 3, 2010
9. M. Wujec, M. Pitucha, M. Dobosz, U. Korsikowka, and A. Malm, Acta Pharm., 2004, 54, 251.
10. T. Karabasanagouda, A. V. Adhikari, and N. Shetty, Eur. J. Med. Chem., 2007, 42, 521.
11. B. Kahveci, M. Ozil, E. Mentese, O. Bekircan, and K. Buruk, Russ. J. Org. Chem., 2008, 44, 1816.
12. J. Stefanska, M. Struga, S. Tyski, J. Kossakowski, and M. Dobosz, Pol. J. Microbiol., 2008, 57, 179.
13. F. H. Havaldar and A. R. Patil, E-J. Chem., 2008, 5, 347.
14. I. Tumosienė, K. Kantminienė, A. Pavilonis, Ž. Maželienė, and Z. J. Beresnevičius, Heterocycles,
2009, 78, 59.
15. Y. Unver, E. Dugdu, K. Sancak, M. Er, and S. Alpay Karaoglu, Turk. J. Chem., 2009, 33, 135.
16. A. S. Labinskaja, ´Microbiology with the technique of microbiological investigations, ´Medicina,
Moscow, 1972. (in Russian)
17. G. N. Pershin, ´Methods of experimental chemotherapy, ´Medicina, Moscow, 1971. (in Russian)